Reactivity of lymphocytes to basic proteins prepared from brain glioma and stomach cancer with MEM test.
作者信息
Shi Y D, Tang Z S, Lian Z J, Lu C Z, Xiao B G
出版信息
Br J Cancer. 1981 Apr;43(4):532-6. doi: 10.1038/bjc.1981.76.
Abstract
摘要
相似文献
1
Reactivity of lymphocytes to basic proteins prepared from brain glioma and stomach cancer with MEM test.
Br J Cancer. 1981 Apr;43(4):532-6. doi: 10.1038/bjc.1981.76.
2
Lymphocyte reactivity to allogeneic tumor antigens and myelin basic protein in gastric cancer patients.
Gan. 1977 Aug;68(4):449-57.
3
[Biochemistry of brain tumor--brain tumor protein and immune reactions (author's transl)].
No Shinkei Geka. 1974 Oct;2(10):655-61.
4
Responses of cancer patients in the MEM test: not just a function of charge on basic proteins.
Br J Cancer. 1976 Jul;34(1):7-13. doi: 10.1038/bjc.1976.114.
5
Lymphocyte sensitization and ageing.
Gerontologia. 1972;18(4):185-92. doi: 10.1159/000211932.
6
Autoradiographic and fluorescence antibody studies of the human host immune response to gliomas.
Neurology. 1972 Mar;22(3):246-50. doi: 10.1212/wnl.22.3.246.
7
Cell electrophoresis for diagnostic purposes. I. Diagnostic value of the electrophoretic mobility test (EMT) for the detection of gynaecological malignancies.
Br J Cancer. 1981 May;43(5):588-97. doi: 10.1038/bjc.1981.88.
8
Immunological tumour profile: organ-specific carcinoma diagnosis in patients employing the macrophage electrophoretic mobility test.
Cancer Lett. 1977 Jan;2(3):139-45. doi: 10.1016/s0304-3835(77)80003-7.
9
The macrophage electrophoretic mobility test: Results on carcinoma of the colon and rectum.
Int J Cancer. 1977 Apr 15;19(4):474-81. doi: 10.1002/ijc.2910190407.
10
Studies on lymphocyte sensitization to encephalitogenic protein in tumor patients.
Acta Neuropathol Suppl. 1975;Suppl 6:65-8. doi: 10.1007/978-3-662-08456-4_10.
本文引用的文献
1
Technical aspects of the macrophage electrophoretic mobility (MEM) test for malignant disease.
Br J Cancer Suppl. 1973 Aug;1:229-36.
2
The chemical nature of cancer basic protein.
Br J Cancer Suppl. 1973 Aug;1:224-8.
3
Clinical evaluation of the macrophage electrophoretic mobility test for cancer.
Br J Cancer. 1974 Dec;30(6):532-7. doi: 10.1038/bjc.1974.232.
4
The macrophage electrophoretic mobility (MEM) test for malignant disease. Further clinical investigations and studies on macrophage slowing factors.
Clin Exp Immunol. 1974 Dec;18(4):543-52.
5
Macrophage electrophoretic mobility (MEM) test in cancer: a critical evaluation.
Br J Cancer Suppl. 1973 Aug;1:208-14.
6
The macrophage electrophoretic migration test in cancer.
Clin Exp Immunol. 1973 Jul;14(3):469-72.
7
Macrophage-electrophoretic-mobility (M.E.M.) test for malignant disease. An independent confirmation.
Lancet. 1972 Sep 23;2(7778):627-9. doi: 10.1016/s0140-6736(72)93018-8.
8
Failure to obtain positive MEM tests in either cell-mediated immune conditions in the guinea-pig or in human cancer.
Br J Cancer. 1977 Nov;36(5):545-9. doi: 10.1038/bjc.1977.229.
9
Changes in structuredness of cytoplasmic matrix in single stimulated lymphocytes from healthy donors and patients with non-malignant and malignant diseases.
Br J Cancer. 1979 Jul;40(1):156-60. doi: 10.1038/bjc.1979.152.
10
Application of the phenomenon of changes in the structuredness of cytoplasmic matrix (SCM) in the diagnosis of malignant disorders: a review.
Eur J Cancer (1965). 1977 Sep;13(9):903-15. doi: 10.1016/0014-2964(77)90166-9.
Zotero 插件